Navigation Links
Scientists locate key hormone involved in appetite control

A key hormone involved in appetite control, called ghrelin, has been identified by researchers from the Oregon Health & Science University(OHSU). Scientists have demonstrated the effect of the hormone on the brain and have shown that the hormone activated the specialized neurons in the hypothalamus involved in weight regulation. Ghrelin is a hormone produced in the stomach with the ability to stimulate feeding when introduced to specialized weight regulating brain cells called neuropeptide Y neurons. Lead author Michael Cowley, Ph.D., added that past// research has shown that increasing ghrelin levels in mice for an extended period resulted in weight gain. Ghrelin is believed to be part of the body's natural signaling system which informs the brain when it's time to eat. In both mice and humans, ghrelin levels increase naturally in response to weight loss or reduced caloric intake and the hormone diminishes in response to food intake.

The scientists used a method pioneered by OHSU researchers Cowley, Roger Cone, Ph.D., and Malcolm Low, M.D., Ph.D. to pinpoint and witness the effects of the hormone in the brain. They used a fluorescent protein to highlight certain neurons, making the brain cells distinguishable from other surrounding neurons. They then used tiny electrodes to record cell activity in response to ghrelin. The researchers have also located a new source for ghrelin production in the body. The site is located in a section of the hypothalamus that had no previously known function and that is near the brain region affected by the hormone.

Researchers believed that this new discovery could be used to develop drugs aimed at stimulating appetite in patients who have undergone extreme weight loss due to illness, a condition known as cachexia, and in finding new drugs that would assist children who are developing at a slower than normal rate. On the other hand, drugs aimed at limiting production of the hormone might be developed to reduce a
'"/>




Page: 1 2

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists open the book of life
4. Scientists review SARS
5. Scientists crack dengue fever puzzle
6. Scientists push to lower hidden sodium in food
7. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
8. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
9. Scientists reveal the secrets of sarcasm
10. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
11. Scientists Warn Against Food Borne Illnesses
Post Your Comments:
(Date:7/18/2008)...d Mexican Cuisine are Featured at East LA Meets Na... Services Corporation, LOS ANGELES, July 18 /PRNe...d annual East LA Meets Napa celebration featuring ... wine makers and 20 Los Angeles area Mexican,resta...wine and culinary,enthusiasts who enjoyed great mu...
(Date:7/18/2008)...on the wagon an antidepressant restored brain,s ab... 18 (HealthDay News) -- Giving up your few drinks ...ion, a new study says. , "Our research in an an...nence from alcohol drinking and depression," study...hiatry and pharmacology in the University of North...
(Date:7/18/2008)...t weight loss yields significant health benefits, ...lition -- a group of,experts on overweight and obe...a to reevaluate the way they report on weight loss... news coverage and editorial content that,leads co...ieters if they,lose an enormous amount of weight, ...
(Date:7/18/2008)...Is Not What America Signed Up For, WASHINGTON, Ju...cCain,s,top economic advisor, Phil Gramm, echoed M...were "psychological" by saying Americans are in a ...nation of whiners." While McCain,distanced himself...d as,McCain,s top economic adviser. Now, John McCa...
Breaking Medicine News(10 mins):Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 2Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 3Health News:Research Finds Causal Link Between Ending Drinking, Depression 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 3Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3
...us University Hospital, Denmark, in a first of its...with a group of ankle injury patients. They found ... in the neck, head, shoulder, arm and even lower b...y of the two groups, pain in the ankle injury grou...
... toenails is a problem that occurs in 1 in 2 perso...y a long standing fungal infection and it gives to...tors at the Mayo Clinic advice consulting with a c...ug. However, these drugs might cause some side eff...
...s Chairman, Tajendra Khanna, in a recent seminar o...ity on 'Managing Corporate Reputation', spoke abou...rugs market. He said that their products would cre...market - Dabur, which has 60 per cent market share...
...r ectopy, another name for premature heart beat, d...searchers to be a better predictor of an increased.... Doctors from Cleveland Clinic Foundation observe...re, valve disease or arrhythmia. They were referre...
Other Medicine News:
(Date:7/16/2008)...orts Pivotal Phase 2b Clinical Trials of First, ...f Cystic Fibrosis -, SOUTH PLAINFIELD, N.J. and B...tics, Inc. (PTC) and Cystic Fibrosis Foundation Th...f the Cystic Fibrosis Foundation, today,announced ...ort development,of PTC124, the PTC,s new investiga...
(Date:7/16/2008)...ly 16 /- MAP,Pharmaceutical...ve results,from a Phase 2 study evaluating the saf...in adult asthmatics were published in the July,iss...armaceuticals is,developing MAP0004, an orally inh... treatment for migraine., The study results, whic...
(Date:7/15/2008)...ewswire/ -- Abeome Corporation, a,Georgia-based bi...investment by Cato BioVentures and a collaboration...arch and development organization. The investment,...lopment of Abeome,s lead,ovarian cancer project., ...he development of,monoclonal antibodies and Abeome...
(Date:7/15/2008)...of Phase III Trials of Light Infusion Therapy,in H...Cancer and Phase I/II and Phase IIa Beni..., July 15 /- Light Sciences Oncology,...ight Infusion Therapy(TM),(Litx(TM)) to treat canc...as raised $40.1 million in a Series C round of fin...
Breaking Medicine Technology:PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 2PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 3PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 4MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Light Sciences Oncology Raises $40.1 Million in Series C Financing 2WuXi PharmaTech Completes Acquisition of AppTec 2919 1WuXi PharmaTech Completes Acquisition of AppTec 2919 2Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 1Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 2Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 3DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call 2917 1MITs McGovern Institute researchers awarded 248 5M to study brain basis of autism and dyslexia 10682 1MITs McGovern Institute researchers awarded 248 5M to study brain basis of autism and dyslexia 10682 2
...ENCE, Italy - 8 March 2007 - Cancer drug,developer...unces,positive initial findings from its second, c...cell lung cancer. , This 30-patient trial tested a...rboplatin and paclitaxel chemotherapy.,Investigato...of,patients showed disease stabilisation, while on...
...evelopment program of first-in-class CB1,antagonis...ion and,avoid image as life-style drug , BARCELONA...ce,firm La Merie S.L. reported today that Sanofi-A...ia (rimonabant) has at least,five competitors in c...rlier phases of R&D. While Acomplia received E...
Other Medicine Technology:Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 2Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 3Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3
A variety of surgical drapes that provide a vertical barrier to keep the C-arm isolated from the sterile surgical field during hip/femur fracture or trauma procedures. Available with pouches and with
...ll-in-one procedure drape made of 3M™ Steri-...elastic aperture, to create a sterile field during...ake draping quick and convenient by eliminating th...remity drapes with elastic apertures suitable for ...
...OCT, which includes bed side and near patient test...osed unique problems for hospitals and clinical la...sibility to decentralized areas focused on patient... the problem is the reality of controlling staffin...
The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incub
Medicine Products: